These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 5525114)

  • 1. [Biochemical, pharmacological and clinical observations in connection with the broncho-secretolytic, bisolvon].
    Rossini G
    Med Monatsschr; 1970 Jun; 24(6):270-2. PubMed ID: 5525114
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with a new secretolytic drug.
    Villa R; Orlandini GC
    Minerva Med; 1969 Sep; 60(76):3607-10. PubMed ID: 5823759
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the treatment of some forms of acute and chronic bronchial diseases with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Trombini V
    Minerva Med; 1969 Sep; 60(76):3600-3. PubMed ID: 5823757
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of treatment with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride in oral adminstration on bronchial secretions; cytological findings].
    Lenzini L; Barnabè R
    Minerva Med; 1969 Sep; 60(76):3580-2. PubMed ID: 5823754
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Bisolvon on tracheobronchial secretion of the horse suffering from chronic lung disease].
    Schatzmann U; Bürgi H; Straub R
    Dtsch Tierarztl Wochenschr; 1973 Mar; 80(5):97-100. PubMed ID: 4572499
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical considerations on a recent preparation with bronchial secretolytic action].
    Santilli E; Castellana G
    Minerva Med; 1969 Sep; 60(76):3583-93. PubMed ID: 5823755
    [No Abstract]   [Full Text] [Related]  

  • 7. [Decrease of lung-dependent surgical risk through systematic secretolysis].
    Zeth K
    Med Monatsschr; 1973 May; 27(5):226-9. PubMed ID: 4732368
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with a new preparation with bronchosecretolytic action: Bisolvon or N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Ercillo L; Mollica G
    Minerva Med; 1969 Sep; 60(76):3604-6. PubMed ID: 5823758
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical observations on the effects of the association of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride and oxytetracycline in acute and chronic bronchopathies].
    Bini P; Romagnoli E
    Clin Ter; 1970 Dec; 55(5):433-59. PubMed ID: 5516108
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of a new substance with secretolytic action].
    Bontà L
    Minerva Med; 1969 Sep; 60(75):3525-44. PubMed ID: 5344813
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bisolvomycin and Bisolvon in the treatment of chronic bronchitis, bronchial asthma and bronchiectasis].
    Mijusković B; Macanović J
    Plucne Bolesti Tuberk; 1972; 24(3):229-33. PubMed ID: 4571639
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of a broncho-secretolytic in lung specialties with the help of a simple measuring method].
    Wilde W
    Arztl Forsch; 1966 Mar; 20(3):149-56. PubMed ID: 6014420
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bisolvon: secretolysis, cell-protection, infection control].
    Heynen U
    Z Allgemeinmed; 1970 Apr; 46(11):586-9. PubMed ID: 5522696
    [No Abstract]   [Full Text] [Related]  

  • 14. A new mucolytic, bromhexine ("bisolvon"). A double-blind study.
    Bateman PP
    Med J Aust; 1971 May; 1(18):963-5. PubMed ID: 4930812
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of N-cyclohexyl-N-methyl(-2-amino-3,5-dibromobenzyl)-ammonium chloride associated with antibiotics in therapy of chronic bronchopneumopathies].
    Quilici G; Da Porto R
    Clin Ter; 1970 Sep; 54(6):495-517. PubMed ID: 5527647
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bisolvon in pneumological practice].
    Ollagnier C; Vallon MC
    Lyon Med; 1969 Dec; 222(46):1233-5. PubMed ID: 4905093
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with the new secretolytic Bisolvon].
    Junge W; Günthner W; Haslreiter E; Hess K; Loos M
    Med Klin; 1965 Dec; 60(51):2058-61. PubMed ID: 5332371
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of bromhexine therapy on concentrations of oxytetracycline in the sol phase of sputum.
    Brogan TD; Allen L; Hutt H; Ryley HC
    Br J Clin Pract; 1972 Dec; 26(12):555-8. PubMed ID: 4649365
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pulmonary volumetric changes caused by N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Brignani F; Cavalli A; Fabbri M; Melica A
    Minerva Med; 1969 Sep; 60(75):3545-8. PubMed ID: 5344814
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of proteolytic enzymes in the complex treatment of chronic non-specific diseases of the lungs].
    Komarova IA; Sokolovskaia MV
    Ter Arkh; 1971 Aug; 43(8):78-81. PubMed ID: 5151782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.